Risk of fracture in Ankylosing spondylitis patient on TNF inhibitor
According to data published in Arthritis Care & Research, the introduction of tumor necrosis factor inhibitors (TNFi) in 2003 was not successful in preventing fracture …
Ankylosing spondylitis
Phases IIa trial reports that tildrakizumab treatment did not improve ASAS20 response rate in ankylosing spondylitis patients
An anti-interleukin-23p19 monoclonal antibody known as tildrakizumab has received approval for treating moderate to severe plaque psoriasis. However, a recent study published in the Journal …
Systematic review finds an association between suicidal behavior and depression in psoriatic arthritis patients
The burden of autoimmune disease extends beyond physical symptoms. It includes factors such as anxiety, stigma, and their impact on well-being, which can adversely affect …